CN103385986A - Chinese medicine tincture for treating leucoderma - Google Patents
Chinese medicine tincture for treating leucoderma Download PDFInfo
- Publication number
- CN103385986A CN103385986A CN2013103211476A CN201310321147A CN103385986A CN 103385986 A CN103385986 A CN 103385986A CN 2013103211476 A CN2013103211476 A CN 2013103211476A CN 201310321147 A CN201310321147 A CN 201310321147A CN 103385986 A CN103385986 A CN 103385986A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- chinese medicine
- skin
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicine tincture for treating leucoderma. The Chinese medicine tincture is composed of 26 traditional Chinese medicines: schizonepeta, saposhnidoviae radix, mint, scorpion, periostracum cicada, ginseng, astragalus root, peach kernel, angelica sinensis, ligusticum wallichii, white peony root, prepared rhizome of rehmannia, pseudo-ginseng, glossy privet fruit, eclipta alba, fructus psoraleae, radix angelicae, saffron crocus, fig, lithospermum, flatstem milkvetch seed, fructus cnidii, polygonum multiflorum, dark plum, borneol and clove. The medicine liquid is applied to an infected part by using a cotton swab; the medicine is capable of dredging the channels, promoting blood circulation to remove blood stasis, and promoting circulation of Qi and blood so as to help dispel wind pathogen. Formulation of melanin in skin is the standard for judging health recuperation; the key enzyme, namely tyrosinase for formation of a pigment in body, has a key catalytic effect in a pigment synthesis process. Therefore, all medicines capable of activating the tyrosinase and enhancing the activity thereof are capable of increasing melanin, and can possibly recover the color of a depigmentation region of leucoderma suffering skin.
Description
Technical field:
The present invention relates to traditional Chinese medical science patent medicine, especially a kind ofly be used for the treatment of leukodermic Traditional Chinese medicine tincture preparation.
Background technology:
Vitiligo is a kind of common dermatosis, and with a long history, can trace back to B.C..So far still perplexing China's " millions of people, its hazardness is not only to affect appearance, but also to the patient, imposes serious mental pressure.Although the leukodermic cause of disease, pathogeny are still not clear so far, scholar both domestic and external is more extensive to the research of this disease.I excavate, arrange through clinical practice in more than 40 years research from motherland's medical science, rebuild the good recipe of Chinese medicine diagnosis and treatment primary disease, and with the dialectical factorial of theory of Chinese medical science, through clinical verification repeatedly, the present invention has good curative effect to vitiligo.
Summary of the invention:
The present invention is comprised of 20 Six-element Chinese medicines such as Herba Schizonepetae, Radix Saposhnikoviae, Herba Menthae, Scorpio, Periostracum Cicadae, Radix Ginseng, the Radix Astragali, Semen Persicae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Radix Rehmanniae Preparata, Radix Notoginseng, Fructus Ligustri Lucidi, Herba Ecliptae, Fructus Psoraleae, the Radix Angelicae Dahuricae, Stigma Croci, Fructus Fici, Radix Arnebiae (Radix Lithospermi), Semen Astragali Complanati, Fructus Cnidii, Radix Polygoni Multiflori, Fructus Mume, Borneolum Syntheticum, Flos Caryophyllis.
The ancient vitiligo that claims of vitiligo, according in medical word is succinct, penetrating, generality is strong characteristic analysis, its " wind " word represents the primary disease cause of disease substantially, represents visually again pathogenesis and the symptom feature of primary disease.Ailment said due to cold or exposure is first of six climate exopathogens, the length of all kinds of diseases and ailments, be also other external causes of disease the guide with depend on, other the external cause of disease depends on ailment said due to cold or exposure and imports human body and cause disease.Vitiligo is multiple in two seasons of spring and summer, and is especially many in morbidity in season in the early spring and development, is that wind is held under the arm due to warm heresy.Illustrate that ailment said due to cold or exposure is the key factor that causes the primary disease morbidity.Scorpio in side, property is flat, walks and does not keep the ailment said due to cold or exposure of the exterior and the interior inside and outside ceasing; In addition Herba Schizonepetae, Radix Saposhnikoviae, Herba Menthae, the loose evil dispelling wind of Periostracum Cicadae; Radix Ginseng, the Radix Astragali, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Radix Rehmanniae Preparata can enrich blood empty, dry, and invigorating primordial QI improves autoimmunity invading with anti-exopathogen.But Radix Notoginseng, Stigma Croci dredging the meridian, blood circulation promoting and blood stasis dispelling, get through QI and blood to help by ailment said due to cold or exposure; In skin, whether melanic formation is the standard that this disease is recovered, and play critical catalytic action in the key enzyme one tryrosinase pigment synthesis process of chromogenesis in body, so can activate tryrosinase, strengthen its active medicine, melanin is increased, all have to make from purplish or white patches on the skin wind skin pigment and take off the possibility of losing district's secondary color.Get Rhizoma Chuanxiong, Fructus Ligustri Lucidi, lotus grass, Fructus Fici, Radix Arnebiae (Radix Lithospermi), Semen Astragali Complanati, Fructus Cnidii, Radix Polygoni Multiflori in we, Fructus Mume activates and strengthen tyrosinase activity, impels melanin to form, and with Fructus Psoraleae, the Radix Angelicae Dahuricae increase skin photosensitive, hold back black.Borneolum Syntheticum has the effect of causing resuscitation with aromatic drugs, analgesic antiphlogistic, but priming is by the through space between skin and muscles of flesh table; Contain eugenol, Flos Caryophylli volatile oil in Flos Caryophylli, with Borneolum Syntheticum, share, the good short effect of oozing is both arranged, be natural plant thoroughly stare at so that effective ingredient be penetrated into subcutaneous, thereby repair white macula, activate melanocyte, improve body constitution, regulate immunity, fundamentally treat primary disease.
The specific embodiment:
get Herba Schizonepetae 30g, Radix Saposhnikoviae 30g, Herba Menthae 30g, Scorpio 20g, Periostracum Cicadae 20g, Radix Ginseng 20g, Radix Astragali 50g, Semen Persicae 20g, Radix Angelicae Sinensis 20g, Rhizoma Chuanxiong 30g, Radix Paeoniae Alba 30g, Radix Rehmanniae Preparata 30g, Radix Notoginseng 25g, Fructus Ligustri Lucidi 40g, Herba Ecliptae 40g, Fructus Psoraleae 60g, Radix Angelicae Dahuricae 30g, Stigma Croci 15g, Fructus Fici 35g, Radix Arnebiae (Radix Lithospermi) 30g, Semen Astragali Complanati 60g, Fructus Cnidii 40g, Radix Polygoni Multiflori 40g, Fructus Mume 40g, Borneolum Syntheticum 20g, Flos Caryophylli 15g is through selected drying, the 52 In Shade sealings of degree Chinese liquor 8L that in whole except Borneolum Syntheticum after pulverizing with pulverizer is rough, medicinal grain is brewageed were soaked 45 days, then use filtered through gauze, add Borneolum Syntheticum 20g after the filtering residue, enter that wine is instant and to be distributed into some bottles after in addition a little stirs standby.
Using method: with cotton swab, be stained with the medicinal liquid affected part of exterior coating, 6 to 12 times on the one, one month is a course for the treatment of, serious symptom 2 was to 3 months courses for the treatment of, the patient with severe symptoms coordinates oral fair complexion loose: fair complexion is loose removes Fructus Broussonetiae for recipes in ancient times " Huanshao pill ", adds Radix Notoginseng 5g, Radix Salviae Miltiorrhizae 15g, Herb Gynostemmae Pentaphylli 15g, Radix Rhodiolae 10g, Semen Persicae 15g, Fructus Psoraleae 20g, Radix Ginseng 15g, Radix Astragali 30g form. and the treatment spleen-kidney vacuity cold, QI and blood is frail, poor appetite is weak, the floating toothache of gum, poliosis senilism, the dry white macula of skin etc. have distinguished curative effect.The patient with severe symptoms takes that fair complexion is loose coordinates the suitable Exposure to Sunlight in affected part simultaneously, but Shorten the Treatment Process accelerates melanin and forms.
Avoid and points for attention: the wine of 1, banning on opium-smoking and the opium trade during the treatment, avoid pungent stimulation food, note regulating spirit, mental pressure.
2, not drinkable, do not enter mouth and nose and skin sensitivity place.
3, there is outer injury to use.
4, anemia of pregnant woman's forbidding.
The present invention is by collect using the second half year in 2012 patient's 96 examples of the present invention to observe, male's 36 examples, and women's 59 examples, the age 14 is to 56 years old, average 23.7 years old; The course of disease 1 to 16 year, average 43 years.The white macula area is respectively 1 to 13cm and does not wait, and the white macula major part is positioned at the exposure portion such as face, neck, extremity, wherein segmental pattern 37 examples, topical type 31 examples, acra type .19 example, distribute type 9 examples, the more than place of the focus of some patients were.The white macula area approaches or, greater than patient with severe symptoms 32 people of the skin surface gross area 1/4th, accounts for total number of persons 1/3rd.Above patient all normally uses one course for the treatment of of the present invention, and the patient with severe symptoms coordinates oral fair complexion to fall apart and 2 the each Exposure to Sunlight of 45 minutes treatments every day.
Efficacy assessment standard:
1, recovery from illness: the normal colour of skin of white macula full recovery or close with the normal colour of skin.
2, produce effects: white macula occurs that the pigment area accounts for former white macula area 〉=50%.
3, take a turn for the better: white macula occur that the pigment area accounts for former white macula area>I20% but<50%, and (or) outwards enlarge gradually.
4, invalid: white macula occurs that the pigment area accounts for former white macula area<20%, or pigment do not occur, or disappears again after occurring.
5, total effective rate adds produce effects, improvement total with recovery from illness, and obvious effective rate adds up to recovery from illness, produce effects.
Recovery from illness 23 examples, account for 24% after a course of therapy; Produce effects 42 examples, account for 43%; 24 examples that take a turn for the better, account for 25%; Invalid 3 examples, stopped treatment person 4 examples, account for 8% midway; Total effective rate 92%, obvious effective rate 67%.
Model case:
Wu, man, 60 years old, the Taiyuan, Shanxi people, private prosecution was suffered from vitiligo 20 years, through the net effect of in many ways seeking medical advice, introduce the here diagnosis and treatment through another patient, (the back shirtfront of area 3cm * 4cm), the both arms white macula that all differs in size, be diagnosed as vitiligo disease to look into its left side of neck oval type white macula, wipe affected part through using a kind of the treatment outside leukodermic Traditional Chinese medicine tincture preparation, take simultaneously Huanshao pill plus-minus side produce effects after three courses for the treatment of, pigment dwindles, and illing skin is near normal color of the leather.
Lee, the man, 40 years old, people from Laifeng County, Hubei, heavy cold was suffered from one time in readme before 15 years, and the Semen Glycines Great White Spot appears in both hands, extends in time, and is increasing.When examined in June, 2010, both hands had become white, are diagnosed as vitiligo disease, throw a kind of vitiligo Traditional Chinese medicine tincture preparation for the treatment of and wipe affected part outward.Give simultaneously oral Huanshao pill, plus-minus side, accused more after three courses for the treatment of, follows up a case by regular visits to drug withdrawal one place without recurrence.
Zhao so-and-so, man, 43 years old, people from Laifeng County, Hubei, readme was suffered from vitiligo 19 years, and both arms both hands white macula differs in size, many places, maximum 3cm * 5cm, be diagnosed as vitiligo disease, throw and a kind ofly treat leukodermic Traditional Chinese medicine tincture preparation and wipe affected part outward, four the course for the treatment of affected part color of the leather near the normal skin color.
Claims (1)
1. treat leukodermic Traditional Chinese medicine tincture preparation for one kind, it is characterized in that the weight of prescription formula and kind Chinese medicine: Herba Schizonepetae 30g, Radix Saposhnikoviae 30g, Herba Menthae 30g, Scorpio 20g, Periostracum Cicadae 20g, Radix Ginseng 20g, Radix Astragali 50g, Semen Persicae 20g, Radix Angelicae Sinensis 20g, Rhizoma Chuanxiong 30g, Radix Paeoniae Alba 30g, Radix Rehmanniae Preparata 30g, Radix Notoginseng 25g, Fructus Ligustri Lucidi 40g, Herba Ecliptae 40g, Fructus Psoraleae 60g, Radix Angelicae Dahuricae 30g, Stigma Croci 15g, Fructus Fici 35g, Radix Arnebiae (Radix Lithospermi) 30g, Semen Astragali Complanati 60g, Fructus Cnidii 40g, Radix Polygoni Multiflori 40g, Fructus Mume 40g, Borneolum Syntheticum 20g, Flos Caryophylli 15g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310321147.6A CN103385986B (en) | 2013-07-23 | 2013-07-23 | Chinese medicine tincture for treating leucoderma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310321147.6A CN103385986B (en) | 2013-07-23 | 2013-07-23 | Chinese medicine tincture for treating leucoderma |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103385986A true CN103385986A (en) | 2013-11-13 |
CN103385986B CN103385986B (en) | 2015-04-22 |
Family
ID=49530521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310321147.6A Expired - Fee Related CN103385986B (en) | 2013-07-23 | 2013-07-23 | Chinese medicine tincture for treating leucoderma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103385986B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103623174A (en) * | 2013-12-04 | 2014-03-12 | 宋明柱 | Leucoderma capsule |
CN103977107A (en) * | 2014-05-22 | 2014-08-13 | 刘增艳 | Traditional Chinese medicine composition for treating leucoderma |
CN104173408A (en) * | 2014-09-10 | 2014-12-03 | 陈远征 | Pharmaceutical composition for treating urticaria disease and preparation method thereof |
CN104257857A (en) * | 2014-10-11 | 2015-01-07 | 李敬文 | Medicine for treating vitiligo |
CN105998183A (en) * | 2016-06-24 | 2016-10-12 | 凌云 | Compound traditional Chinese medicine micro needle transdermal patch for treating leucoderma and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1456180A (en) * | 2002-05-08 | 2003-11-19 | 马宏裕 | Medicine for curing leucoderma and preparing method thereof |
CN101574431A (en) * | 2009-06-17 | 2009-11-11 | 赵富刚 | Drug for treating vitligo |
CN101874866A (en) * | 2009-12-23 | 2010-11-03 | 泰一和浦(北京)中医药研究院有限公司 | External Chinese medicinal composition for treating calvities and alopecia areata and preparation method thereof |
CN102145123A (en) * | 2011-03-30 | 2011-08-10 | 黄泳葛 | Three-in-one speckle removing technology |
-
2013
- 2013-07-23 CN CN201310321147.6A patent/CN103385986B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1456180A (en) * | 2002-05-08 | 2003-11-19 | 马宏裕 | Medicine for curing leucoderma and preparing method thereof |
CN101574431A (en) * | 2009-06-17 | 2009-11-11 | 赵富刚 | Drug for treating vitligo |
CN101874866A (en) * | 2009-12-23 | 2010-11-03 | 泰一和浦(北京)中医药研究院有限公司 | External Chinese medicinal composition for treating calvities and alopecia areata and preparation method thereof |
CN102145123A (en) * | 2011-03-30 | 2011-08-10 | 黄泳葛 | Three-in-one speckle removing technology |
Non-Patent Citations (1)
Title |
---|
张丽: "抑黑方和促黑方调节人黑色素瘤A375细胞黑色素合成及酪氨酸酶活性的研究", 《中国优秀硕士学位论文全文数据库》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103623174A (en) * | 2013-12-04 | 2014-03-12 | 宋明柱 | Leucoderma capsule |
CN103977107A (en) * | 2014-05-22 | 2014-08-13 | 刘增艳 | Traditional Chinese medicine composition for treating leucoderma |
CN103977107B (en) * | 2014-05-22 | 2016-08-24 | 程晓燕 | One treats leukodermic Chinese medicine composition |
CN104173408A (en) * | 2014-09-10 | 2014-12-03 | 陈远征 | Pharmaceutical composition for treating urticaria disease and preparation method thereof |
CN104257857A (en) * | 2014-10-11 | 2015-01-07 | 李敬文 | Medicine for treating vitiligo |
CN105998183A (en) * | 2016-06-24 | 2016-10-12 | 凌云 | Compound traditional Chinese medicine micro needle transdermal patch for treating leucoderma and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103385986B (en) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101816742A (en) | Chinese medicinal composition for treating hemorrhoids and preparation method thereof | |
CN103385986B (en) | Chinese medicine tincture for treating leucoderma | |
CN101559195A (en) | Epilepsy therapy capsule and preparation method thereof | |
CN103479929A (en) | Traditional Chinese medicine composition for treating pruritus | |
CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
CN102600426B (en) | Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof | |
CN102266488B (en) | Medicament for treating leucoderma | |
CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
CN102416145B (en) | Chinese medicinal composition for treating menstrual disorder | |
CN102078435B (en) | Medicinal oil for treating pityriasis rosea and preparation method thereof | |
CN101057922B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
CN102240391B (en) | Traditional Chinese medicine solution for health promotion | |
CN102600351B (en) | Traditional Chinese medicine for treating pruritus cutanea | |
CN101623455B (en) | Medicine for treating prostate hyperplasia | |
CN104491806A (en) | External traditional Chinese medicine for treating allergic rhinitis | |
CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
CN103055055A (en) | Traditional Chinese medicine for treating skin diseases | |
CN103007213A (en) | Chinese medicinal composition for treating arthralgia | |
CN105796714A (en) | Traditional Chinese medicine acupoint plaster | |
CN105963635A (en) | Traditional Chinese medicinal composition for treating headache | |
CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
CN103735829A (en) | Traditional Chinese medicine composition for treating spontaneous perspiration | |
CN102988890A (en) | Pure Chinese medicine preparation for treating chloasma | |
CN102670943A (en) | Chinese medicinal preparation for treating cervical headache |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20200723 |